High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
Dungarwalla, Moez
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy. [electronic resource] - Haematologica Mar 2008 - 475-6 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Letter
1592-8721
10.3324/haematol.11903 doi
Adult
Aged
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Agents--adverse effects
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Combined Modality Therapy
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Humans
Immunotherapy--adverse effects
Infection Control
Infections--etiology
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Male
Methylprednisolone--adverse effects
Middle Aged
Rituximab
Salvage Therapy
Vidarabine--administration & dosage
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy. [electronic resource] - Haematologica Mar 2008 - 475-6 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Letter
1592-8721
10.3324/haematol.11903 doi
Adult
Aged
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Murine-Derived
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Agents--adverse effects
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Combined Modality Therapy
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Humans
Immunotherapy--adverse effects
Infection Control
Infections--etiology
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Male
Methylprednisolone--adverse effects
Middle Aged
Rituximab
Salvage Therapy
Vidarabine--administration & dosage